Literature DB >> 20505394

Academic retainer medicine: an innovative business model for cross-subsidizing primary care.

David J Lucier1, Nicholas B Frisch, Brian J Cohen, Michael Wagner, Deeb Salem, David G Fairchild.   

Abstract

Retainer-medicine primary care practices, commonly referred to as "luxury" or "concierge" practices, provide enhanced services to patients beyond those available in traditional practices for a yearly retainer fee. Adoption of retainer practices has been largely absent in academic health centers (AHCs). Reasons for this trend stem primarily from ethical concerns, such as the potential for patient abandonment when physicians downsize from larger, traditional practices to smaller, retainer-medicine practices.In 2004, the Department of Medicine at Tufts Medical Center developed an academic retainer-medicine primary care practice within the Division of General Medicine that not only generates financial support for the division but also incorporates a clinical and business model that is aligned with the mission and ethics of an academic institution.In contrast to private retainer-medicine practices, this unique business model addresses several of the ethical issues associated with traditional retainer practices-it does not restrict net access to care and it neutralizes concerns about patient abandonment. Addressing the growing primary care shortage, the model also presents the opportunity for a retainer practice to cross-subsidize the expansion of general medicine in an academic medical setting. The authors elucidate the benefits, as well as the inherent challenges, of embedding an academic retainer-medicine practice within an AHC.

Entities:  

Mesh:

Year:  2010        PMID: 20505394     DOI: 10.1097/ACM.0b013e3181dbe19e

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  1 in total

1.  Uninsured patient opinions about a reduced-fee retainer program at academic health center clinics.

Authors:  John W Saultz; John Heineman; Rachel Seltzer; Arwen Bunce; Leneva Spires; Jennifer Devoe
Journal:  J Am Board Fam Med       Date:  2011 May-Jun       Impact factor: 2.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.